Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Cancer Research|August 21, 2025
Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer ProgressionVaradha Balaji Venkadakrishnan, Adam Presser, Nathaniel C E Voss, et al.
JCO Precision Oncology|September 19, 2025
Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate CancerRuben Raychaudhuri, Isla P Garraway, Kara N Maxwell, et al.
BJU International|November 1, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)Daniel J Lee, Eugene K Cha, Justin M Dubin, et al.
The American Journal of Surgical Pathology|April 8, 2014
Proposed morphologic classification of prostate cancer with neuroendocrine differentiationJonathan I Epstein, Mahul B Amin, Himisha Beltran, et al.
Neoplasia (New York, N.Y.)|April 5, 2013
Epigenomic alterations in localized and advanced prostate cancerPei-Chun Lin, Eugenia G Giannopoulou, Kyung Park, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancerStéphane Terry, Pascale Maillé, Habiba Baaddi, et al.
Histopathology|December 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosisJeanne M Dsouza, Erolcan Sayar, Michael T Schweizer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Aggressive variants of castration-resistant prostate cancerHimisha Beltran, Scott Tomlins, Ana Aparicio, et al.
Genome Biology|August 28, 2014
Unraveling the clonal hierarchy of somatic genomic aberrationsDavide Prandi, Sylvan C Baca, Alessandro Romanel, et al.
Pageof 25